PRIMECAP MANAGEMENT CO 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-08 11:50 am Sale |
2022-11-30 | 13G | Wave Life Sciences Ltd. WVE |
PRIMECAP MANAGEMENT CO | 4,225,908 4.860% |
-368,667 (-8.02%) |
Filing |
| 2022-02-10 12:29 pm Purchase |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
PRIMECAP MANAGEMENT CO | 4,594,575 7.810% |
670,100 (+17.07%) |
Filing |
| 2021-02-12 12:02 pm Purchase |
2009-02-28 | 13G | Wave Life Sciences Ltd. WVE |
PRIMECAP MANAGEMENT CO | 3,924,475 8.050% |
3,924,475 (New Position) |
Filing |